Science
NASA abandons InSight mission to crack the surface of Mars – Yahoo Finance Australia
Martian soil does not behave in the way NASA engineers expected.
San Diego, Calif, Jan. 15, 2021 (GLOBE NEWSWIRE) — Emerald Bioscience, Inc. (OTCQB: EMBI) (EMBI or the Company), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has changed its name from Emerald Bioscience, Inc. to Skye Bioscience, Inc. The Company will trade under its new ticker symbol, SKYE, on the OTC effective at market open on Tuesday, January 19, 2021. About Emerald Bioscience,…
-
Noosa News21 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News19 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General24 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Business6 hours agoFord CEO makes stunning prediction about artificial intelligence